Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Study of CRLX101 (Formerly Named IT-101) in the Treatment of Advanced Solid Tumors
This study has been completed.
Study NCT00333502 Information provided by Cerulean Pharma Inc.
First Received on June 1, 2006. Last Updated on July 30, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Antineoplastic Agents, Phytogenic
Molecular Mechanisms of Pharmacological Action
Topoisomerase I Inhibitors
Sponsors listed in this trial
Cerulean Pharma Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers